Literature DB >> 19264679

Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program.

Norma Maugeri1, Patrizia Rovere-Querini, Virgilio Evangelista, Cesare Covino, Annalisa Capobianco, Maria T S Bertilaccio, Antonio Piccoli, Licia Totani, Domenico Cianflone, Attilio Maseri, Angelo A Manfredi.   

Abstract

Activated platelets express ligands, which are recognized by counterreceptors on neutrophils. Here, we show that the ensuing cell-to-cell interaction programs neutrophil phagocytic function, resulting in activated platelet clearance. Neutrophils that have internalized platelets circulate in the blood of patients with acute myocardial infarction, and the extent of platelet clearance correlates with expression of platelet activation, including P-selectin. Activated platelets injected intravenously in experimental animals are detectable in circulating neutrophils 60 minutes after, and within 3 hours, more than 70% circulating neutrophils have internalized platelets. Platelet clearance comprises 2 events: adhesion to neutrophils, which requires divalent cations and depends on P-selectin, on the P-selectin glycoprotein ligand-1 (PSGL-1), and on the CD11b/CD18 beta2 integrin; and internalization, which is abrogated by the phosphatidylserine-binding protein annexin A5. Adhesion to platelets causes neutrophil degranulation and is blocked by antibodies specific for P-selectin and PSGL-1, either in a synthetic medium in vitro or in the whole blood, therefore in the presence of a physiologic array of plasma cofactors and opsonins. The data suggest that the interaction between circulating platelets and neutrophils influences innate immune functions, possibly contributing to regulate vascular inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264679     DOI: 10.1182/blood-2008-09-180794

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

Review 1.  Platelets: a critical link between inflammation and microvascular dysfunction.

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

2.  Human platelet FcγRIIA and phagocytes in immune-complex clearance.

Authors:  Zhen-Yu Huang; Paul Chien; Zena K Indik; Alan D Schreiber
Journal:  Mol Immunol       Date:  2010-12-17       Impact factor: 4.407

Review 3.  Platelet-leukocyte interactions in cardiovascular disease and beyond.

Authors:  Licia Totani; Virgilio Evangelista
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

4.  CD8+ T cells mediate antibody-independent platelet clearance in mice.

Authors:  Connie M Arthur; Seema R Patel; H Cliff Sullivan; Annie M Winkler; Chris A Tormey; Jeanne E Hendrickson; Sean R Stowell
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

5.  Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and Fc RIIa in immune thrombocytopenia.

Authors:  Rolf T Urbanus; Dianne E van der Wal; Cornelis A Koekman; Albert Huisman; Dave J van den Heuvel; Hans C Gerritsen; Hans Deckmyn; Jan-Willem N Akkerman; Roger E G Schutgens; Eelo Gitz
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

6.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

Review 7.  Regulation of leucocyte homeostasis in the circulation.

Authors:  Christoph Scheiermann; Paul S Frenette; Andrés Hidalgo
Journal:  Cardiovasc Res       Date:  2015-03-05       Impact factor: 10.787

8.  Standardization in flow cytometry: correct sample handling as a priority.

Authors:  Andrea Valle; Norma Maugeri; Angelo A Manfredi; Manuela Battaglia
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

Review 9.  In Vitro models for thrombogenicity testing of blood-recirculating medical devices.

Authors:  Deepika N Sarode; Shuvo Roy
Journal:  Expert Rev Med Devices       Date:  2019-06-10       Impact factor: 3.166

10.  Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungs.

Authors:  Kagya A Amoako; Patrick J Montoya; Terry C Major; Ahmed B Suhaib; Hitesh Handa; David O Brant; Mark E Meyerhoff; Robert H Bartlett; Keith E Cook
Journal:  J Biomed Mater Res A       Date:  2013-04-24       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.